Published on 2 Apr 2024 on Investing.com
Acorda Therapeutics to be delisted from Nasdaq amid Chapter 11
Acorda Therapeutics , Inc. (NASDAQ: ACOR ), a biotechnology company focused on developing therapies...
NASDAQ.ACOR price evolution
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free